Evidence map›Paper›PMID 31149268›Full record

ArticleActa endocrinologica (Bucharest, Romania : 2005)

TG/HDL-C RATIO AS CARDIO-METABOLIC BIOMARKER EVEN IN NORMAL WEIGHT WOMEN.

G Borrayo, L Basurto, E González-Escudero, A Diaz, A Vázquez, L Sánchez, G O Hernández-González, S Barrera, J A Degollado, N Córdova and 1 more

Open access · greenAbstract readCase Reports
In one paragraph

Article in Acta endocrinologica (Bucharest, Romania : 2005). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 54 citations in OpenAlex.

  1. Current perspectives on lipid management in diabetic kidney disease: Can fibrates offer advantages over statins for renal outcomes?Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. The prognostic significance of insulin resistance in COVID-19: a review.Journal of diabetes and metabolic disorders · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Increased Insulin Resistance in Hepatitis-C Infection-Association with Altered Hepatic Function Testing.Pathophysiology : the official journal of the International Society for Pathophysiology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

G BorrayoCardiology Hospital National Medical Center, Mexico City, México.
L BasurtoEndocrine Research Unit, National Medical Center, Instituto Mexicano del Seguro Social, Mexico City, México.
E González-EscuderoEndocrine Research Unit, National Medical Center, Instituto Mexicano del Seguro Social, Mexico City, México.
A DiazEndocrine Research Unit, National Medical Center, Instituto Mexicano del Seguro Social, Mexico City, México.
A VázquezEndocrine Research Unit, National Medical Center, Instituto Mexicano del Seguro Social, Mexico City, México.
L SánchezUniversidad Veracruzana, School of Medicine, Mexico City, México.
G O Hernández-GonzálezUniversidad Veracruzana, School of Medicine, Mexico City, México.
S BarreraSchool National of Medicine, Instituto Politécnico Nacional, Mexico City, México.
J A DegolladoNational Medical Center, Department of Radiology, Mexico City, México.
N CórdovaEndocrine Research Unit, National Medical Center, Instituto Mexicano del Seguro Social, Mexico City, México.
F AvelarNational Medical Center, Department of Radiology, Mexico City, México.
National Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextDespite that the Triglycerides/High Density Lipoprotein Cholesterol (TG/HDL-C) ratio has been associated with insulin resistance and cardiovascular disease, some outcomes differ between populations.

objectiveThe objective of this study was to evaluate the association between TG/HDL-C ratio and cardio-metabolic risk factors in both obese and normal weight women.

designCross sectional, from January to December of 2015. SUBJECTS AND

methodsTwo hundred and fifty three women aged 40 to 60 years. Anthropometric and laboratory measurements were performed. Insulin resistance was measured by the homeostasis model assessment for insulin resistance (HOMA-IR). All participants underwent a Doppler ultrasound to measure intima-media thickness of carotid artery (cIMT).

resultsTG/HDL-C ratio correlated with body mass index (r=0.194, p=0.01), and visceral adipose tissue (r=0.193, p=0.002). Additionally, TG/HDL-C correlated with glucose (r=0.367, p=0.001), insulin (r=0.354, p=0.001) and HOMA-IR (r=0.396 p=0.001). TG/HDL-C was associated with prediabetes, Odds Ratio (OR) was 1.83 (95%CI 1.07-3.13) and insulin resistance 3.27 (95%CI 1.78-6.01), and this risk remains in normal weight women 4.7 (95%CI 1.2-17.81) for prediabetes and 4.38 (95%CI 1.42-13.84) for insulin resistance. No significant risk for cIMT.

conclusionA TG/HDL-C ratio ≥ 3.0 is a potential risk factor for prediabetes and insulin resistance in women 40-60 years, even in normal weight women.

Indexed as

Carotid Intima-Media ThicknessInsulin ResistancePrediabetesTG/HDL-C

Identifiers

PMID31149268
PMCPMC6516523
OpenAlexW2883964551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.